Latest Ratios: P/E Ratio 33.6x · EV/EBITDA 20.6x · ROE 16.2%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $15.9B | $13.2B | $14.3B | $12.3B | $13.1B | $14.9B | $11.3B | $9.1B | $7.2B | $7.4B | $5.8B |
| Enterprise Value | $18.0B | $15.3B | $16.6B | $14.1B | $13.9B | $15.7B | $12.5B | $10.2B | $8.5B | $8.9B | $6.7B |
| P/E Ratio → | 33.61 | 27.26 | 30.57 | 25.13 | 25.54 | 32.84 | 45.30 | 27.08 | 19.17 | 24.94 | 21.17 |
| P/S Ratio | 5.71 | 4.73 | 5.31 | 4.66 | 5.06 | 6.32 | 5.33 | 4.16 | 3.21 | 3.57 | 3.18 |
| P/B Ratio | 5.35 | 4.34 | 4.87 | 4.72 | 5.71 | 6.92 | 6.43 | 5.77 | 4.98 | 6.38 | 6.76 |
| P/FCF | 24.11 | 19.97 | 29.04 | 20.19 | 28.39 | 29.41 | 25.03 | 28.64 | 17.43 | 26.51 | 21.31 |
| P/OCF | 22.16 | 18.36 | 25.68 | 19.11 | 25.54 | 27.35 | 22.51 | 23.84 | 14.33 | 21.09 | 17.39 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 5.46 | 6.16 | 5.36 | 5.36 | 6.64 | 5.87 | 4.66 | 3.75 | 4.30 | 3.70 |
| EV / EBITDA | 20.56 | 17.43 | 20.45 | 17.96 | 17.32 | 21.81 | 26.92 | 17.25 | 13.85 | 15.94 | 14.58 |
| EV / EBIT | 24.83 | 21.06 | 24.57 | 20.88 | 20.68 | 26.15 | 37.35 | 21.40 | 16.99 | 19.44 | 17.16 |
| EV / FCF | — | 23.07 | 33.69 | 23.23 | 30.09 | 30.89 | 27.57 | 32.12 | 20.40 | 31.93 | 24.75 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 55.2% | 55.2% | 55.2% | 54.2% | 55.1% | 56.1% | 53.3% | 54.3% | 54.8% | 55.1% | 54.9% |
| Operating Margin | 25.9% | 25.9% | 25.1% | 25.6% | 27.1% | 26.0% | 16.5% | 22.0% | 22.3% | 22.6% | 21.5% |
| Net Profit Margin | 17.4% | 17.4% | 17.4% | 18.5% | 19.8% | 19.2% | 11.8% | 15.4% | 16.7% | 14.3% | 15.0% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 16.2% | 16.2% | 16.9% | 19.9% | 23.0% | 23.2% | 14.9% | 22.2% | 29.0% | 29.5% | 36.0% |
| ROA | 8.1% | 8.1% | 8.3% | 10.7% | 13.5% | 12.2% | 6.9% | 9.7% | 11.0% | 10.1% | 11.4% |
| ROIC | 10.5% | 10.5% | 10.5% | 13.4% | 17.6% | 15.9% | 9.4% | 13.5% | 14.1% | 15.7% | 16.5% |
| ROCE | 13.6% | 13.6% | 13.3% | 17.6% | 22.2% | 18.5% | 11.0% | 15.8% | 17.2% | 19.2% | 18.7% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.71 | 0.71 | 0.82 | 0.75 | 0.41 | 0.49 | 0.77 | 0.80 | 0.92 | 1.38 | 1.17 |
| Debt / EBITDA | 2.47 | 2.47 | 2.96 | 2.49 | 1.19 | 1.46 | 2.93 | 2.12 | 2.17 | 2.87 | 2.17 |
| Net Debt / Equity | — | 0.67 | 0.78 | 0.71 | 0.34 | 0.35 | 0.65 | 0.70 | 0.85 | 1.30 | 1.09 |
| Net Debt / EBITDA | 2.34 | 2.34 | 2.82 | 2.34 | 0.98 | 1.04 | 2.48 | 1.87 | 2.02 | 2.70 | 2.03 |
| Debt / FCF | — | 3.10 | 4.65 | 3.03 | 1.71 | 1.48 | 2.54 | 3.48 | 2.97 | 5.42 | 3.44 |
| Interest Coverage | 7.16 | 7.16 | 7.58 | 11.34 | 29.97 | 23.52 | 10.37 | 10.14 | 10.05 | 12.48 | 18.28 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.64 | 1.64 | 2.41 | 2.11 | 1.36 | 2.62 | 2.81 | 2.12 | 2.52 | 1.37 | 2.25 |
| Quick Ratio | 1.05 | 1.05 | 1.51 | 1.33 | 0.90 | 1.88 | 2.05 | 1.52 | 1.77 | 0.96 | 1.58 |
| Cash Ratio | 0.14 | 0.14 | 0.22 | 0.20 | 0.20 | 0.67 | 0.57 | 0.32 | 0.27 | 0.14 | 0.20 |
| Asset Turnover | — | 0.47 | 0.45 | 0.50 | 0.68 | 0.62 | 0.58 | 0.62 | 0.66 | 0.61 | 0.75 |
| Inventory Turnover | 2.81 | 2.81 | 2.52 | 2.65 | 3.04 | 3.17 | 3.58 | 3.54 | 3.85 | 3.51 | 3.70 |
| Days Sales Outstanding | — | 76.86 | 80.69 | 82.05 | 75.71 | 75.62 | 81.20 | 88.29 | 79.55 | 89.19 | 86.47 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 1.1% | 1.4% | 1.1% | 1.2% | 1.0% | 0.7% | 0.8% | 0.9% | 1.0% | 0.9% | 1.0% |
| Payout Ratio | 37.0% | 37.0% | 34.5% | 30.8% | 24.5% | 21.5% | 35.4% | 24.4% | 19.2% | 21.6% | 20.8% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 3.0% | 3.7% | 3.3% | 4.0% | 3.9% | 3.0% | 2.2% | 3.7% | 5.2% | 4.0% | 4.7% |
| FCF Yield | 4.1% | 5.0% | 3.4% | 5.0% | 3.5% | 3.4% | 4.0% | 3.5% | 5.7% | 3.8% | 4.7% |
| Buyback Yield | 1.9% | 2.3% | 0.2% | 0.7% | 2.0% | 0.4% | 0.5% | 1.3% | 0.3% | 0.0% | 0.6% |
| Total Shareholder Yield | 3.0% | 3.7% | 1.4% | 2.0% | 3.0% | 1.1% | 1.2% | 2.2% | 1.3% | 0.9% | 1.6% |
| Shares Outstanding | — | $57M | $58M | $58M | $58M | $59M | $58M | $58M | $59M | $58M | $58M |
Acquisition-driven goodwill concentration
According to current market data, Nordson trades at a forward P/E of 25.98, which appears to command a premium relative to traditional industrial machinery peers, suggesting that investors are pricing in the company's specialized exposure to high-growth medical and semiconductor end-markets rather than cyclical industrial volumes.
The current P/E multiple of 35.43 TTM implies that the market views Nordson as a high-quality compounder rather than a standard industrial manufacturer. While this valuation is elevated compared to broader industrial averages, it may be justified by the company's recurring revenue from consumables and its critical role in advanced semiconductor packaging.
Based on reported financial statements, Nordson's ROIC has hovered between 2.0% and 3.1% over the last ten quarters, a figure that appears suppressed by the significant accumulation of goodwill and intangible assets resulting from the company's aggressive inorganic growth strategy within the ATS segment.
The relatively low ROIC relative to peers like Illinois Tool Works suggests that while the underlying business is highly profitable, the capital base is heavily inflated by acquisition premiums. Investors should monitor whether the Ascent framework can drive sufficient operational efficiencies to improve these returns on invested capital over the coming cycles.
As reported in recent filings, Nordson's cash conversion cycle remains elevated, peaking at 210 days in 2025Q1 and settling at 158 days in 2026Q2, which indicates that the company's inventory-heavy model requires significant working capital to support its specialized, non-standardized product offerings across global markets.
The high days inventory outstanding, which reached 156 days in 2025Q1, reflects the necessity of maintaining deep stock for specialized components in the ATS segment. This extended cycle warrants further investigation into whether supply chain optimization can reduce these requirements without compromising the company's ability to meet critical customer delivery timelines.
Based on an analysis of market sentiment, the most commonly misapplied ratio for Nordson is the standard industrial P/E, which obscures the defensive, non-discretionary nature of its medical and semiconductor-linked revenue streams that behave more like a high-margin life sciences or technology business than a cyclical machinery firm.
Applying a generic industrial P/E multiple fails to account for the high switching costs and recurring revenue from consumables that provide a floor during economic downturns. Analysts should instead consider an EV/EBITDA approach adjusted for the amortization of acquisition-related intangibles to better capture the true cash-generating power of the core business.
Includes 30+ ratios · 30 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying NDSN stock.
Nordson Corporation's current P/E ratio is 33.6x. The historical average is 23.1x. This places it at the 90th percentile of its historical range.
Nordson Corporation's current EV/EBITDA is 20.6x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 13.5x.
Nordson Corporation's return on equity (ROE) is 16.2%. The historical average is 20.9%.
Based on historical data, Nordson Corporation is trading at a P/E of 33.6x. This is at the 90th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Nordson Corporation's current dividend yield is 1.10% with a payout ratio of 37.0%.
Nordson Corporation has 55.2% gross margin and 25.9% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
Nordson Corporation's Debt/EBITDA ratio is 2.5x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.